Northland raised the firm’s price target on BioLife Solutions to $28 from $26 and keeps an Outperform rating on the shares after the company reported better-than-expected results and its third consecutive quarter of double-digit sequential growth.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLFS: